HCW Biologics Regained Compliance with Bid Price Rule Per Nasdaq Compliance Letter

Company now compliant with all continued listing rules for Nasdaq Company now compliant with all continued listing rules for Nasdaq

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.